CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L, Bochud PY, Golshayan D, Crettol S, Venetz JP, Manuel O, Kutalik Z, Treyer A, Lehmann R, Mueller NJ, Binet I, van Delden C, Steiger J, Mohacsi P, Dufour JF, Soccal PM, Pascual M, Eap CB; The Swiss Transplant Cohort Study.
Quteineh L, et al.
Pharmacogenomics J. 2017 Jan;17(1):69-75. doi: 10.1038/tpj.2015.82. Epub 2015 Dec 8.
Pharmacogenomics J. 2017.
PMID: 26644205
Free article.